Status:
COMPLETED
Non-Specific Effects of Standard Titre Measles Vaccination
Lead Sponsor:
Bandim Health Project
Collaborating Sponsors:
International Cooperation with Developing Countries
Danish Council for Development Research
Conditions:
Measles
Eligibility:
All Genders
6-8 years
Phase:
PHASE4
Brief Summary
The general objectives of the proposed research work are: A1) to reduce childhood mortality in developing countries through better control of measles infection by finding the best immunization strate...
Detailed Description
Background. Measles is the major killer among vaccine preventable diseases with an estimated one million deaths/year in developing countries. Though a good vaccine exists, the current immunization str...
Eligibility Criteria
Inclusion
- Infants of 6 months of age registered in the Bandim Health Project registration system and currently living in the Bandim Health Project areas: Bandim I, Bandim II, Belem and Mindará
Exclusion
- Severe illness requiring hospitalisation
Key Trial Info
Start Date :
March 1 1995
Trial Type :
INTERVENTIONAL
End Date :
January 1 2006
Estimated Enrollment :
7800 Patients enrolled
Trial Details
Trial ID
NCT00168662
Start Date
March 1 1995
End Date
January 1 2006
Last Update
February 26 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bandim Health Project
Bissau, Apartado 861, Guinea-Bissau, 1004 Bissau Codex